Sabra Health Care REIT (SBRA) Stock Forecast & Price Target

$18.84 +0.32 (+1.73%)

(As of 11/26/2024 ET)

Sabra Health Care REIT - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 7 Analyst Ratings

Sell
0

Hold
1

Buy
6

Based on 7 Wall Street analysts who have issued ratings for Sabra Health Care REIT in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 1 has given a hold rating, and 6 have given a buy rating for SBRA.

Consensus Price Target

$18.71
-0.67% Downside

According to the 7 analysts' twelve-month price targets for Sabra Health Care REIT, the average price target is $18.71. The highest price target for SBRA is $21.00, while the lowest price target for SBRA is $17.00. The average price target represents a forecasted downside of -0.67% from the current price of $18.84.

Get the Latest News and Ratings for SBRA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sabra Health Care REIT and its competitors.

SBRA Analyst Ratings Over Time

Type	Current Forecast 11/27/23 to 11/26/24	1 Month Ago 10/28/23 to 10/27/24	3 Months Ago 8/29/23 to 8/28/24	1 Year Ago 11/27/22 to 11/27/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	5 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$18.71	$18.38	$16.60	$14.59
Forecasted Upside	-0.67% Downside	-2.26% Downside	-1.13% Downside	0.70% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

❗[Investor Alert] Under-the-Radar Tech (Ad)

While most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One company that most have never heard of is making waves in the global music market…TuneGO

Click here for all the details about today's open round of investing.

SBRA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SBRA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Sabra Health Care REIT Stock vs. The Competition

Type	Sabra Health Care REIT	Finance Companies	S&P 500
Consensus Rating Score	2.86	2.49	2.50
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	1.05% Upside	8.96% Upside	6.38% Upside
News Sentiment Rating	Very Positive News See Recent SBRA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/11/2024	Scotiabank 5 of 5 stars		Boost Target	Sector Perform ➝ Sector Perform	$17.00 ➝ $18.00	+0.11%
10/1/2024	Wells Fargo & Company 3 of 5 stars	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$16.00 ➝ $20.00	+7.47%
9/13/2024	Citigroup 3 of 5 stars	N. Joseph Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$17.00 ➝ $20.00	+8.99%
9/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$16.00 ➝ $18.00	+4.23%
2/29/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$17.00	+22.92%
1/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$21.00	+55.79%
❗[Investor Alert] Under-the-Radar Tech (Ad) While most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One company that most have never heard of is making waves in the global music market…TuneGO Click here for all the details about today's open round of investing.
1/3/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$15.00 ➝ $17.00	+19.63%
11/7/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$14.00 ➝ $16.00	+14.94%
10/17/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Market Perform	$16.00	+9.89%
10/10/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$14.00 ➝ $16.00	+14.20%
9/20/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$11.00 ➝ $15.00	+12.28%
7/27/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$13.00	-0.99%
4/25/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$15.00 ➝ $13.00	+18.18%
4/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral	$13.00	+10.64%
12/13/2022	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:27 PM ET.

SBRA Forecast - Frequently Asked Questions

: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Sabra Health Care REIT is $18.71, with a high forecast of $21.00 and a low forecast of $17.00.
: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last twelve months. There is currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SBRA shares.
: According to analysts, Sabra Health Care REIT's stock has a predicted downside of -0.67% based on their 12-month stock forecasts.
: Over the previous 90 days, Sabra Health Care REIT's stock had 2 upgrades by analysts.
: Sabra Health Care REIT has been rated by research analysts at Citigroup, Scotiabank, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Sabra Health Care REIT more than other "finance" companies. The consensus rating for Sabra Health Care REIT is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how SBRA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

❗[Investor Alert] Under-the-Radar Tech (Ad)

While most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One company that most have never heard of is making waves in the global music market…TuneGO

Click here for all the details about today's open round of investing.

This page (NASDAQ:SBRA) was last updated on 11/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sabra Health Care REIT (SBRA) Stock Forecast & Price Target